Pharma Mar, S.A. (PHM.MC)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap667.68M
EV667.68M
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
159.0
206.2
193.5
191.8
173.4
91.8
288.7
245.8
210.0
189.4
Revenue % Chg.
5.8%
29.7%
-6.2%
-0.9%
-9.6%
-47.1%
214.6%
-14.9%
-14.6%
-23.6%
Cost of Revenue
37.2
48.9
47.0
48.8
38.4
5.6
14.7
17.6
14.6
12.8
Gross Profit
121.8
157.3
146.5
142.9
135.1
86.2
274.0
228.2
195.4
176.6
Gross Profit Margin
76.6%
76.3%
75.7%
74.5%
77.9%
93.9%
94.9%
92.8%
93.1%
93.2%
R&D Expenses
56.1
64.5
83.9
84.0
79.1
54.2
57.5
77.2
89.2
91.4
Selling, General, & Admin Expenses
65.1
73.4
72.7
70.0
63.4
40.4
38.3
42.5
46.2
44.8
Other Expenses
-21.0
7.4
9.9
7.8
7.7
10.3
11.2
9.8
12.4
16.1
Operating Income
21.6
12.1
-20.0
-18.9
-15.0
-18.7
166.8
98.9
47.1
24.9
Operating Income Margin
13.6%
5.9%
-10.3%
-9.9%
-8.7%
-20.4%
57.8%
40.2%
22.4%
13.2%
Total Other Income/Expenses Net
-6.2
-5.7
-6.4
-5.5
-5.0
-4.5
-11.1
2.9
-0.3
-3.6
Income Before Tax
15.5
6.4
-26.4
-24.4
-20.0
-23.2
155.7
101.7
46.8
21.3
Income Before Tax Margin
9.7%
3.1%
-13.7%
-12.7%
-11.5%
-25.2%
53.9%
41.4%
22.3%
11.3%
Income Tax Expense
1.4
-0.7
-0.6
4.2
-2.7
-13.3
8.9
2.4
-6.0
-9.5
Net Income
14.0
7.0
-25.8
-28.6
-5.9
-9.8
146.8
99.3
52.8
30.8
Net Income Margin
8.8%
3.4%
-13.3%
-14.9%
-3.4%
-10.7%
50.8%
40.4%
25.1%
16.3%
Weighted Avg. Shares Out
18.3
18.4
18.4
18.4
18.4
18.4
18.3
18.1
18.1
18.0
EPS
0.8
0.4
-1.4
-1.5
-0.3
-0.5
8.0
5.5
2.9
1.7
EPS % Chg.
20.0%
-50.0%
—
9.1%
79.2%
66.7%
—
-31.5%
-46.9%
-68.3%
Weighted Avg. Shares Out Dil
18.4
18.4
18.4
18.4
18.4
18.4
18.3
18.1
18.1
18.0
EPS Diluted
0.8
0.4
-1.4
-1.5
-0.3
-0.5
8.0
5.5
2.9
1.7
Interest Income
0.5
0.2
0.2
0.1
0.1
0.0
0.4
0.4
0.9
—
Interest Expense
6.8
5.9
5.6
5.5
5.0
4.2
3.3
3.6
2.5
-2.8
EBIT
9.2
0.7
-31.8
-29.8
-25.0
-27.3
152.7
98.5
45.2
24.1
EBIT Margin
5.8%
0.3%
-16.4%
-15.5%
-14.4%
-29.7%
52.9%
40.1%
21.5%
12.7%
Depreciation & Amortization
5.6
6.7
7.7
7.5
7.3
6.5
0.3
12.3
11.0
6.3
EBITDA
14.8
7.4
-24.0
-22.3
-17.6
-20.8
153.0
110.8
56.2
30.5
EBITDA Margin
9.3%
3.6%
-12.4%
-11.6%
-10.2%
-22.7%
53.0%
45.1%
26.8%
16.1%